ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Hepion Pharmaceuticals Inc

Hepion Pharmaceuticals Inc (HEPA)

0.135
-0.1868
(-58.05%)
終了 1月23日 6:00AM
0.1634
0.0284
(21.04%)
取引時間後: 9:59AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
0.165
買値
0.1635
売値
0.165
出来高
39,892,307
0.121 日の範囲 0.144
0.1348 52 週間の範囲 3.4899
時価総額
前日終値
0.3218
始値
0.1307
最終取引時間
財務取引量
US$ 5,203,716
VWAP
0.130444
平均取引量 (3 か月)
79,847
発行済株式数
6,958,371
配当利回り
-
PER
-0.02
1 株当たり利益 (EPS)
-7.03
歳入
-
純利益
-48.93M

Hepion Pharmaceuticals Inc について

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and... Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Hepion Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker HEPA. The last closing price for Hepion Pharmaceuticals was US$0.32. Over the last year, Hepion Pharmaceuticals shares have traded in a share price range of US$ 0.1348 to US$ 3.4899.

Hepion Pharmaceuticals currently has 6,958,371 shares in issue. The market capitalisation of Hepion Pharmaceuticals is US$2.24 million. Hepion Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.02.

HEPA 最新ニュース

Hepion Pharmaceuticals Announces $9.0 Million Public Offering

EDISON, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic...

Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.

EDISON, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (Nasdaq: HEPA) (the “Company” or “Hepion”), a clinical stage biopharmaceutical company that had been developing a...

Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B

Transaction Creates Opportunity to Share in Potential Upside of Pharma Two B’s Late-Clinical Stage Candidate to Treat Parkinson’s Disease Hepion’s Board Unanimously Recommends Shareholders...

Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Effectiveness of Registration Statement Related to Proposed Merger

KIRYAT ONO, ISRAEL and EDISON, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.3338-66.92060946270.49880.52790.13485541190.35372563CS
4-0.334-66.93386773550.4990.73450.13482126030.43007244CS
12-0.476-74.25897035880.6410.740.1348798470.47576258CS
26-0.865-83.98058252431.031.030.13481234790.70876109CS
52-1.965-92.25352112682.133.48990.1348893651.08262223CS
156-19.461-99.159278508119.62626.60.134821023612.90859497CS
260-110.035-99.8502722323110.21500.134890606040.56704037CS

HEPA - Frequently Asked Questions (FAQ)

What is the current Hepion Pharmaceuticals share price?
The current share price of Hepion Pharmaceuticals is US$ 0.165
How many Hepion Pharmaceuticals shares are in issue?
Hepion Pharmaceuticals has 6,958,371 shares in issue
What is the market cap of Hepion Pharmaceuticals?
The market capitalisation of Hepion Pharmaceuticals is USD 2.24M
What is the 1 year trading range for Hepion Pharmaceuticals share price?
Hepion Pharmaceuticals has traded in the range of US$ 0.1348 to US$ 3.4899 during the past year
What is the PE ratio of Hepion Pharmaceuticals?
The price to earnings ratio of Hepion Pharmaceuticals is -0.02
What is the reporting currency for Hepion Pharmaceuticals?
Hepion Pharmaceuticals reports financial results in USD
What is the latest annual profit for Hepion Pharmaceuticals?
The latest annual profit of Hepion Pharmaceuticals is USD -48.93M
What is the registered address of Hepion Pharmaceuticals?
The registered address for Hepion Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Hepion Pharmaceuticals website address?
The website address for Hepion Pharmaceuticals is www.hepion.com
Which industry sector does Hepion Pharmaceuticals operate in?
Hepion Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
BLBXBlackBoxStocks Inc
US$ 5.53
(227.22%)
229.07M
ASSTAsset Entities Inc
US$ 1.36
(51.11%)
121.67M
STAIScanTech AI Systems Inc
US$ 2.12
(44.22%)
51.68M
JYDJayud Global Logistics Ltd
US$ 3.53
(42.91%)
1.27M
NTRBNutriband Inc
US$ 7.39
(41.84%)
3.88M
STFSStar Fashion Culture Holdings Ltd
US$ 2.62
(-80.61%)
30.25M
HEPAHepion Pharmaceuticals Inc
US$ 0.135
(-58.05%)
39.89M
STBXStarBox Group Holdings Ltd
US$ 0.6201
(-36.50%)
1.63M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 93.51
(-35.73%)
1
JUNSJupiter Neurosciences Inc
US$ 3.61
(-33.39%)
6.87M
IPAImmunoPrecise Antibodies Ltd
US$ 0.6446
(30.75%)
296.43M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.3191
(33.57%)
229.11M
BLBXBlackBoxStocks Inc
US$ 5.53
(227.22%)
229.08M
NVDANVIDIA Corporation
US$ 147.07
(4.43%)
216.62M
RGTIRigetti Computing Inc
US$ 13.89
(-0.64%)
154.54M

HEPA Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock